Stock A000520 SAMIL PHARMACEUTICAL CO.,LTD
Add to a list
To use this feature you must be a member
Log inSign up

Highlights Samil Pharmaceutical Co.,Ltd

Equities

A000520

KR7000520007

End-of-day quote Korea S.E.
Other stock markets
 03:30:00 31/05/2024 am IST 		5-day change 1st Jan Change
8,130 KRW +3.30% Intraday chart for Samil Pharmaceutical Co.,Ltd -1.45% +21.34%
14/05 Samil Pharmaceutical Co.,Ltd Reports Earnings Results for the First Quarter Ended March 31, 2024 CI
14/03 Samil Pharmaceutical Co.,Ltd Reports Earnings Results for the Full Year Ended December 31, 2023 CI

Highlights

Search
See the results
Unlock all the news on all businesses: Never miss an investment opportunity again!
100% Free Registration
Samil Pharmaceutical Co.,Ltd Reports Earnings Results for the First Quarter Ended March 31, 2024
CI
Samil Pharmaceutical Co.,Ltd Reports Earnings Results for the Third Quarter and Nine Months Ended September 30, 2023
CI
Samil Pharmaceutical Co.,Ltd Reports Earnings Results for the First Quarter Ended March 31, 2023
CI
Tranche Update on Samil Pharmaceutical Co.,Ltd's Equity Buyback Plan announced on November 30, 2021.
CI
Tranche Update on Samil Pharmaceutical Co.,Ltd's Equity Buyback Plan announced on November 30, 2021.
CI
Tranche Update on Samil Pharmaceutical Co.,Ltd's Equity Buyback Plan announced on November 30, 2021.
CI
Tranche Update on Samil Pharmaceutical Co.,Ltd's Equity Buyback Plan announced on November 30, 2021.
CI
Samil Pharmaceutical Co.,Ltd's Equity Buyback announced on November 30, 2021, has expired with 125,939 shares, representing 0.99% for KRW 997.71 million.
CI
Samil Pharmaceutical Co.,Ltd Reports Earnings Results for the Third Quarter and Nine Months Ended September 30, 2022
CI
Tranche Update on Samil Pharmaceutical Co.,Ltd's Equity Buyback Plan announced on October 5, 2021.
CI
Tranche Update on Samil Pharmaceutical Co.,Ltd's Equity Buyback Plan announced on October 5, 2021.
CI
Tranche Update on Samil Pharmaceutical Co.,Ltd's Equity Buyback Plan announced on October 5, 2021.
CI
Tranche Update on Samil Pharmaceutical Co.,Ltd's Equity Buyback Plan announced on October 5, 2021.
CI
Samil Pharmaceutical Co.,Ltd's Equity Buyback announced on October 5, 2021, has expired with 119,560 shares, representing 0.94% for KRW 996.5 million.
CI
Samil Pharmaceutical Co.,Ltd Reports Earnings Results for the Second Quarter and Six Months Ended June 30, 2022
CI
Samil Pharmaceutical Co.,Ltd Reports Earnings Results for the First Quarter Ended March 31, 2022
CI
Tranche Update on Samil Pharmaceutical Co.,Ltd's Equity Buyback Plan announced on April 30, 2021.
CI
Tranche Update on Samil Pharmaceutical Co.,Ltd's Equity Buyback Plan announced on April 30, 2021.
CI
Tranche Update on Samil Pharmaceutical Co.,Ltd's Equity Buyback Plan announced on April 30, 2021.
CI
Tranche Update on Samil Pharmaceutical Co.,Ltd's Equity Buyback Plan announced on April 30, 2021.
CI
No results for this search
All News Analyst Reco. Highlights Insiders Transcripts Press Releases Official Publications Other languages Trading Ideas MarketScreener Editorial Features MarketScreener Strategies

Filters

Search

Announcement Date

Since

Until

  1. Stock Market
  2. Equities
  3. A000520 Stock
  4. News Samil Pharmaceutical Co.,Ltd
  5. Highlights